Page 88 - 《中国药房》2025年20期
P. 88

静脉滴注阿奇霉素致儿童药物性肝损伤的临床特征及影响因素

          分析
                 Δ


          李婉慧 ,吕晓倩 ,苏 丹 ,霍保凤 ,陈赫军 ,闫 平(1. 衡水市人民医院小儿内科,河北 衡水 053000;
                           1
                                   1
                                            1
                 1*
                                                             1
                                                    2 #
          2.衡水市人民医院药学部,河北 衡水 053000)
          中图分类号  R985;R978.1;R969.3      文献标志码  A      文章编号  1001-0408(2025)20-2566-05
          DOI  10.6039/j.issn.1001-0408.2025.20.14

          摘   要  目的  分析静脉滴注阿奇霉素致儿童药物性肝损伤(DILI)的临床特征及影响因素。方法  收集衡水市药品不良反应监测
          中心2015年1月-2025年1月报告的157例静脉滴注阿奇霉素致DILI的患儿的临床资料,作为观察组;按照1∶1的比例,回顾性
          收集衡水市人民医院同期收治的静脉滴注阿奇霉素但未发生DILI的患儿的临床资料,作为对照组。分析观察组患儿DILI的临床
          分型、严重程度及预后。通过单因素分析和多因素Logistic回归分析筛选静脉滴注阿奇霉素致儿童DILI的独立危险因素。结果
          157例DILI患儿中,92例(58.60%)为肝细胞损伤型,51例(32.48%)为胆汁淤积型,14例(8.92%)为混合型;DILI严重程度1、2、3级
          分别有117例(74.52%)、33例(21.02%)、7例(4.46%);经停药及对症治疗后,患儿的肝功能均恢复正常。合并使用对乙酰氨基酚
          [OR=3.769,95%CI(1.615,8.235),P=0.021]和阿奇霉素日剂量>10 mg/kg[OR=2.237,95%CI(1.075,4.655),P=0.034]是静脉滴
          注阿奇霉素致儿童DILI的独立危险因素。结论  阿奇霉素致儿童DILI以肝细胞损伤型和胆汁淤积型较为常见,多为轻度,且预后
          较好。合并使用对乙酰氨基酚、阿奇霉素日剂量>10 mg/kg是阿奇霉素致儿童DILI的独立危险因素。
          关键词  阿奇霉素;药物性肝损伤;儿童;临床特征;影响因素


          Analysis of clinical characteristics and influential factors of drug-induced liver injury in children caused by
          intravenous azithromycin
                                  1
          LI Wanhui ,LYU Xiaoqian ,SU Dan ,HUO Baofeng ,CHEN Hejun ,YAN Ping(1.  Dept.  of  Pediatric  Internal
                                                                       2
                   1
                                                                                  1
                                           1
                                                         1
          Medicine,  Hengshui  People’s  Hospital,  Hebei  Hengshui  053000,  China;2.  Dept.  of  Pharmacy,  Hengshui
          People’s Hospital, Hebei Hengshui 053000, China)
          ABSTRACT    OBJECTIVE  To  analyze  the  clinical  characteristics  and  influential  factors  of  drug-induced  liver  injury (DILI)  in
          children  caused  by  intravenous  azithromycin.  METHODS  Clinical  data  of  157  DILI  pediatric  cases  caused  by  intravenous
          azithromycin,  reported  by  the  Hengshui  Adverse  Drug  Reaction  Monitoring  Center  from  January  2015  to  January  2025,  were
          collected  as  the  observation  group.  Clinical  data  of  pediatric  patients  who  received  intravenous  azithromycin  but  did  not  develop
          DILI during the same period at Hengshui People’s Hospital were collected in a 1∶1 ratio to serve as the control group. The clinical
          classification,  severity  and  prognosis  of  DILI  in  pediatric  patients  from  the  observation  group  were  analyzed.  Univariate  and
          multivariate Logistic regression analyses were used to screen the independent risk factors for DILI in children caused by intravenous
          azithromycin.  RESULTS  Among  157  DILI  cases,  92  cases (58.60%)  had  hepatocellular  injury-type,  51  cases (32.48%)  had
          cholestatic-type,  and  14  cases (8.92%)  had  mixed-type.  DILI  severity  was  grade  1  in  117  cases (74.52%),  grade  2  in  33  cases
         (21.02%), and grade 3 in 7 cases (4.46%). Liver function had all recovered after stopping medication and symptomatic treatment.
          Combined  with  acetaminophen  [OR=3.769,  95%CI (1.615,  8.235),  P=0.021],  daily  dose  of  azithromycin>10  mg/kg  [OR=
          2.237,  95%CI (1.075,  4.655),  P=0.034]  were  independent  risk  factors  for  DILI  in  children  caused  by  intravenous  azithromycin.
          CONCLUSIONS Hepatocellular injury-type and cholestatic-type are relatively common in children with DILI caused by intravenous
          azithromycin,  with  mild  severity  being  predominant  and  showing  a  favorable  prognosis.  Combination  with  acetaminophen  and  daily
                                                              dose>10  mg/kg  are  independent  risk  factors  for  azithromycin-
              Δ 基金项目 河北省医学科学研究课题计划项目(No.20220463)
             *第一作者 主管护师。研究方向:儿科临床合理用药。E-mail:                 induced DILI in children.
          38477948@qq.com                                     KEYWORDS    azithromycin;  drug-induced  liver  injury;  children;
              # 通信作者 副主任药师。研究方向:临床药学、药物不良反应监                  clinical characteristics; influential factors
          测。E-mail:blueair2022@163.com


          · 2566 ·    China Pharmacy  2025 Vol. 36  No. 20                            中国药房  2025年第36卷第20期
   83   84   85   86   87   88   89   90   91   92   93